Effects of LAMININE on Normal Blood Sugar Levels
A pilot study was undertaken to observe a possible trend of the effects of Laminine, a dietary supplement, on normalizing blood sugar levels in subjects beginning to experience unhealthy blood sugar levels.
Subjects’ Hgb A1c (hemoglobin marker for blood sugar levels) were assessed at the beginning of the study and after 12 weeks of taking two supplements daily.
Eleven individuals participated in the study. Three subjects took a placebo, four issues with slightly higher than normal Hgb A1c levels took two Laminine daily.
Four subjects who were on “blood sugar lowering medications” previously prescribed, took two Laminine capsules daily.
Metabolic syndrome often shows increasing levels of glucose intolerance. Measures to support persons who are overweight, have sedentary lifestyles, and are showing higher than normal glucose levels but are not classified as diabetic may benefit from taking Laminine.
Although the sample size was small, this preliminary investigation did show a significant difference between glucose levels before and after 12 weeks of supplementation with Laminine.
The difference in the Hgb A1c marker measurements before and after supplementation (a change of 0.475 units) was also statistically significant in Group B, adding additional credence of the noted effect.
This preliminary evaluation shows the possibility that this supplement may have a beneficial effect on helping maintain average blood glucose in subjects at risk for developing high blood glucose and warrants further study with a larger population.
The statistical evaluation of Group C individuals, taking medicines for normalizing high blood glucose levels, illustrated the safety of the supplement as it did not interfere with medication, or significantly alter the measurements as a group.
Only one subject showed a higher rather than lower effect while on the supplement.
Noticeably, one participant in Group C had been taking insulin with Laminine at the start of the study. From the participant’s personal physician’s recommendation, tapered off the insulin, and maintained stable blood sugar levels by the conclusion of the 12 weeks.
All participants in Group B experienced a normalized down-regulation in Hgb A1c levels, and three out of the four participants experienced a positive change in their status in Group C.
Laminine’s cooling evaporative process
It is known that a nine-day fertilized avian egg extract that is not denatured with heat processing could retain fibroblast growth factor (FGF) activity. Because growth factors react with receptor sites on somatic cells or stem cells, this activity could support glucose absorption.
Laminine also contains fish and vegetable protein, affecting glucose tolerance when added to the diet continuously. Continuing studies are warranted on clinical effectiveness and even on the mechanism of action of Laminine.